115
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Retrospective Claims Database Study to Clarify Treatment Reality of Asthma Patients Before and After Referral to a Specialist

, , , , , & show all
Pages 9-19 | Received 30 Aug 2023, Accepted 21 Dec 2023, Published online: 06 Feb 2024

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2023. Available from: https://ginasthma.org/. Accessed August 8, 2023.
  • Mortimer K, Lesosky M, García-Marcos L, et al; Global Asthma Network Phase I Study Group. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. Eur Respir J. 2022;60(3):2102865. doi:10.1183/13993003.02865-2021
  • Fukutomi Y, Nakamura H, Kobayashi F, et al. Nationwide cross-sectional population-based study on the prevalences of asthma and asthma symptoms among Japanese adults. Int Arch Allergy Immunol. 2010;153(3):280–287. doi:10.1159/000314369
  • Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
  • Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Tran TN. Burden of chronic oral corticosteroid use by adults with persistent asthma. J Allergy Clin Immunol Pract. 2017;5(4):1050–1060.e9. doi:10.1016/j.jaip.2016.12.023
  • Matsunaga K, Hirano T, Oka A, et al. Progression of irreversible airflow limitation in asthma: correlation with severe exacerbations. J Allergy Clin Immunol Pract. 2015;3(5):759–764.e1. doi:10.1016/j.jaip.2015.05.005
  • Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi:10.1186/s12890-017-0409-3
  • Niimi A, Fukunaga K, Taniguchi M, et al. Executive summary: Japanese guidelines for adult asthma (JGL) 2021. Allergol Int. 2023;72(2):207–226. doi:10.1016/j.alit.2023.02.006
  • Japan Asthma Society. Practical Guidelines for Asthma Management 2022. Tokyo: Kyowa Kikaku; 2022. Japanese.
  • Most JF, Ambrose CS, Chung Y, et al. Real-world assessment of asthma specialist visits among U.S. patients with severe asthma. J Allergy Clin Immunol Pract. 2021;9(10):3662–3671.e1. doi:10.1016/j.jaip.2021.05.003
  • Rosman Y, Hornik-Lurie T, Meir-Shafrir K, Lachover-Roth I, Cohen-Engler A, Confino-Cohen R. The effect of asthma specialist intervention on asthma control among adults. World Allergy Organ J. 2022;15(11):100712. doi:10.1016/j.waojou.2022.100712
  • Toyabe S, Kouhei A. Referral from secondary care and to aftercare in a tertiary care university hospital in Japan. BMC Health Serv Res. 2006;6(1):11. doi:10.1186/1472-6963-6-11
  • Japanese Society of Allergology. List of specialists and instructors, Japanese Society of Allergology (for general use). Available from: https://www.jsaweb.jp/modules/ninteilist_general/. Accessed November 25, 2021. Japanese.
  • Japanese Respiratory Society. Specialist search. Available from: https://www.jrs.or.jp/search/specialist/index.php. Accessed August 4, 2023. Japanese.
  • Wang K, Li P, Chen L, Kato K, Kobayashi M, Yamauchi K. Impact of the Japanese diagnosis procedure combination-based payment system in Japan. J Med Syst. 2010;34(1):95–100. doi:10.1007/s10916-008-9220-2
  • Nagase H, Adachi M, Matsunaga K, et al. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergol Int. 2020;69(1):53–60. doi:10.1016/j.alit.2019.06.003
  • Inoue H, Kozawa M, Milligan KL, Funakubo M, Igarashi A, Loefroth E. A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan. NPJ Prim Care Respir Med. 2019;29(1):13. doi:10.1038/s41533-019-0128-8
  • Matsunaga K, Hamada K, Oishi K, Yano M, Yamaji Y, Hirano T. Factors associated with physician-patient discordance in the perception of asthma control. J Allergy Clin Immunol Pract. 2019;7(8):2634–2641. doi:10.1016/j.jaip.2019.04.046
  • Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849–858. doi:10.1016/S2213-2600(15)00367-7
  • Belda J, Parameswaran K, Lemière C, Kamada D, O’Byrne PM, Hargreave FE. Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J. 2006;13(3):129–133. doi:10.1155/2006/189127
  • Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST
  • Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control. Eur Respir J. 2014;43(2):474–484. doi:10.1183/09031936.00048513
  • Pavord ID, Barnes PJ, Lemière C, Gibson PG. Diagnosis and assessment of the asthmas. J Allergy Clin Immunol Pract. 2023;11(1):1–8. doi:10.1016/j.jaip.2022.09.034
  • Health Insurance Bureau Medical Division, Ministry of Health, Labour and Welfare. Overview of FY2022 medical fee revision outpatient I. Available from: https://www.mhlw.go.jp/content/12400000/000920428.pdf. Accessed August 4, 2023. Japanese.